NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|6755050|ref|NP_035207|]
View 

phosphate-regulating neutral endopeptidase PHEX [Mus musculus]

Protein Classification

M13 family metallopeptidase( domain architecture ID 10171382)

M13 family metallopeptidase similar to neutral endopeptidase (neprilysin), which degrades and inactivates bioactive peptides, and to endothelin-converting enzyme, which catalyzes the hydrolysis of the bond between Trp-21 and Val-22 in big endothelin to form endothelin 1

EC:  3.4.24.-
Gene Ontology:  GO:0008270|GO:0008237
MEROPS:  M13
PubMed:  18215274|7674922
SCOP:  3001975

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
74-740 0e+00

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


:

Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 736.48  E-value: 0e+00
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050   74 VDPCENFFRFACDGWISNNPIPEDMPSYGVYPWLRHNVDLKLKALLEKSVSRRRDTEAVQKAKILYSSCMNEKAIEKADA 153
Cdd:cd08662   1 VDPCDDFYQYACGNWLKNHPIPADKSSWGSFSELQDRNEEQLREILEEAASSAADSSAEQKAKDFYKSCMDEEAIEKLGL 80
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050  154 KPLLHILRHspfrwpvleanIGPegvWSERKFSLLQTLATFRGQYSNSVFIRLYVSPDDKASNEHILKLDQATLSLAVRE 233
Cdd:cd08662  81 KPLKPLLDK-----------IGG---LPSLDDLAAELLLALLRRLGVSLLFGLGVSPDPKNSSRNILYLGQPGLGLPDRD 146
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050  234 DFLDntTEAKSYRDALYKFMVDTAVLLGANSSRAEHDMKSVLRLEIKIAEIMIP-HENRTSEAMYNKMNISELSAMIPQF 312
Cdd:cd08662 147 YYLD--EENAEIREAYKKYIAKLLELLGADEEEAEKLAEDVLAFETELAKISLSsEELRDPEKTYNPLTLAELQKLAPSI 224
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050  313 DWLGYIKKVIDtrlyphlkDIGPSENVVVRVPQYFKDLFRILGAERKKTIANYLVWRMVYSRIPNLSRRFQYRWLEFSRV 392
Cdd:cd08662 225 DWKAYLKALGP--------PADDPDKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLDSLAPYLSKEFRDARFFYGKA 296
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050  393 IQGTTTLLPQWDKCVNFIESALPYVVGKMFVNVHFQEDKKEMMEELIEGVRWAFIDMLEkENEWMDAGTKRKAQEKARAV 472
Cdd:cd08662 297 LSGQKEPEPRWKRCVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLE-NLDWMDEETKKKALEKLDAM 375
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050  473 LAKVGYPEFIMNDTYVNEDLKAIKFSeSDYFGNVLQTRKYLAQSDFFWLRKAVPKTEWFTNPTTVNAFYSASTNQIRFPA 552
Cdd:cd08662 376 KVKIGYPDKWRDYSALDIYYDDLNVS-DSYFENVLRLLRFETKRQLAKLGKPVDRTEWSMSPQTVNAYYNPSLNEIVFPA 454
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050  553 GELQKPFFwGTEYPRSLSYGAIGVIVGHEFTHGFDNNGRKYDKNGNLDPWWSVESEEKFKEKTKCMINQYSNYYWKKaGL 632
Cdd:cd08662 455 GILQPPFF-DPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQYSNYEVPP-GL 532
                       570       580       590       600       610       620       630       640
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050  633 NVKGKRTLGENIADNGGLREAFRAYRKWINDRrqgvEEPLLPGITFTNNQLFFLSYAHVRCNSYRPEAAREQVQIGAHSP 712
Cdd:cd08662 533 HVNGKLTLGENIADNGGLRLAYRAYKKWLKEN----GPELPGLEGFTPEQLFFLSFAQVWCSKYRPEALRQLLLTDPHSP 608
                       650       660
                ....*....|....*....|....*...
gi 6755050  713 PQFRVNGAISNFEEFQKAFNCPRNSTMN 740
Cdd:cd08662 609 GKFRVNGPLSNSPEFAEAFNCPPGSPMN 636
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
74-740 0e+00

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 736.48  E-value: 0e+00
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050   74 VDPCENFFRFACDGWISNNPIPEDMPSYGVYPWLRHNVDLKLKALLEKSVSRRRDTEAVQKAKILYSSCMNEKAIEKADA 153
Cdd:cd08662   1 VDPCDDFYQYACGNWLKNHPIPADKSSWGSFSELQDRNEEQLREILEEAASSAADSSAEQKAKDFYKSCMDEEAIEKLGL 80
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050  154 KPLLHILRHspfrwpvleanIGPegvWSERKFSLLQTLATFRGQYSNSVFIRLYVSPDDKASNEHILKLDQATLSLAVRE 233
Cdd:cd08662  81 KPLKPLLDK-----------IGG---LPSLDDLAAELLLALLRRLGVSLLFGLGVSPDPKNSSRNILYLGQPGLGLPDRD 146
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050  234 DFLDntTEAKSYRDALYKFMVDTAVLLGANSSRAEHDMKSVLRLEIKIAEIMIP-HENRTSEAMYNKMNISELSAMIPQF 312
Cdd:cd08662 147 YYLD--EENAEIREAYKKYIAKLLELLGADEEEAEKLAEDVLAFETELAKISLSsEELRDPEKTYNPLTLAELQKLAPSI 224
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050  313 DWLGYIKKVIDtrlyphlkDIGPSENVVVRVPQYFKDLFRILGAERKKTIANYLVWRMVYSRIPNLSRRFQYRWLEFSRV 392
Cdd:cd08662 225 DWKAYLKALGP--------PADDPDKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLDSLAPYLSKEFRDARFFYGKA 296
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050  393 IQGTTTLLPQWDKCVNFIESALPYVVGKMFVNVHFQEDKKEMMEELIEGVRWAFIDMLEkENEWMDAGTKRKAQEKARAV 472
Cdd:cd08662 297 LSGQKEPEPRWKRCVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLE-NLDWMDEETKKKALEKLDAM 375
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050  473 LAKVGYPEFIMNDTYVNEDLKAIKFSeSDYFGNVLQTRKYLAQSDFFWLRKAVPKTEWFTNPTTVNAFYSASTNQIRFPA 552
Cdd:cd08662 376 KVKIGYPDKWRDYSALDIYYDDLNVS-DSYFENVLRLLRFETKRQLAKLGKPVDRTEWSMSPQTVNAYYNPSLNEIVFPA 454
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050  553 GELQKPFFwGTEYPRSLSYGAIGVIVGHEFTHGFDNNGRKYDKNGNLDPWWSVESEEKFKEKTKCMINQYSNYYWKKaGL 632
Cdd:cd08662 455 GILQPPFF-DPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQYSNYEVPP-GL 532
                       570       580       590       600       610       620       630       640
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050  633 NVKGKRTLGENIADNGGLREAFRAYRKWINDRrqgvEEPLLPGITFTNNQLFFLSYAHVRCNSYRPEAAREQVQIGAHSP 712
Cdd:cd08662 533 HVNGKLTLGENIADNGGLRLAYRAYKKWLKEN----GPELPGLEGFTPEQLFFLSFAQVWCSKYRPEALRQLLLTDPHSP 608
                       650       660
                ....*....|....*....|....*...
gi 6755050  713 PQFRVNGAISNFEEFQKAFNCPRNSTMN 740
Cdd:cd08662 609 GKFRVNGPLSNSPEFAEAFNCPPGSPMN 636
PepO COG3590
Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];
68-749 0e+00

Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];


Pssm-ID: 442809 [Multi-domain]  Cd Length: 674  Bit Score: 556.69  E-value: 0e+00
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050   68 SKVNLSVDPCENFFRFACDGWISNNPIPEDMPSYGVYPWLRHNVDLKLKALLEKSVSRRRDTEAVQKaKI--LYSSCMNE 145
Cdd:COG3590  31 ANMDTSVRPGDDFYRYVNGGWLKTTPIPADRSRWGSFNELRERNEARLRAILEEAAAAPAAAGSDEQ-KIgdLYASFMDE 109
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050  146 KAIEKADAKPLLhilrhspfrwPVLE--ANIgpegvwsERKFSLLQTLATFRGQYSNSVFiRLYVSPDDKASNEHILKLD 223
Cdd:COG3590 110 AAIEALGLAPLK----------PDLAriDAI-------KDKADLAALLAALHRAGVGGLF-GFGVDADLKNSTRYIAYLG 171
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050  224 QATLSLAVREDFLDNTTEAKSYRDALYKFMVDTAVLLGANSSRAEHDMKSVLRLEIKIAEIMIPH-ENRTSEAMYNKMNI 302
Cdd:COG3590 172 QGGLGLPDRDYYLKDDEKSAEIRAAYVAHVAKMLELAGYDEADAAAAAEAVLALETALAKAHWSRvELRDPEKTYNPMTV 251
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050  303 SELSAMIPQFDWLGYIKKVidtrlyphlkDIGPSENVVVRVPQYFKDLFRILGAERKKTIANYLVWRMVYSRIPNLSRRF 382
Cdd:COG3590 252 AELAKLAPGFDWDAYLKAL----------GLPAVDEVIVGQPSFFKALDKLLASTPLEDWKAYLRWHLLDSAAPYLSKAF 321
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050  383 QYRWLEF-SRVIQGTTTLLPQWDKCVNFIESALPYVVGKMFVNVHFQEDKKEMMEELIEGVRWAFIDMLEKeNEWMDAGT 461
Cdd:COG3590 322 VDANFDFyGKTLSGQKEQRPRWKRAVALVNGALGEALGQLYVERYFPPEAKARMEELVANLRAAYRERIEN-LDWMSPET 400
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050  462 KRKAQEKARAVLAKVGYPefimnDTYvnEDLKAIKFSESDYFGNVLQTRKylaqsdFFWLR------KAVPKTEWFTNPT 535
Cdd:COG3590 401 KAKALEKLAAFTPKIGYP-----DKW--RDYSGLEIKRDDLVGNVLRASA------FEYQRelaklgKPVDRTEWGMTPQ 467
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050  536 TVNAFYSASTNQIRFPAGELQKPFFwGTEYPRSLSYGAIGVIVGHEFTHGFDNNGRKYDKNGNLDPWWSVESEEKFKEKT 615
Cdd:COG3590 468 TVNAYYNPTMNEIVFPAAILQPPFF-DPKADDAVNYGGIGAVIGHEITHGFDDQGSQFDGDGNLRNWWTPEDRAAFEART 546
                       570       580       590       600       610       620       630       640
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050  616 KCMINQYSNYYWKKaGLNVKGKRTLGENIADNGGLREAFRAYRKwindRRQGVEEPLLPGitFTNNQLFFLSYAHVRCNS 695
Cdd:COG3590 547 KKLVAQYDAYEPLP-GLHVNGKLTLGENIADLGGLSIAYDAYKL----SLKGKEAPVIDG--FTGDQRFFLGWAQVWRSK 619
                       650       660       670       680       690
                ....*....|....*....|....*....|....*....|....*....|....*
gi 6755050  696 YRPEAAREQVQIGAHSPPQFRVNGAISNFEEFQKAFNCPRNSTMNR-GADSCRLW 749
Cdd:COG3590 620 ARDEALRQRLATDPHSPGEFRVNGPVRNLDAFYEAFDVKPGDKMYLaPEDRVRIW 674
Peptidase_M13_N pfam05649
Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of ...
76-479 2.36e-130

Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of organizms including mammals and bacteria. In mammals they participate in processes such as cardiovascular development, blood-pressure regulation, nervous control of respiration, and regulation of the function of neuropeptides in the central nervous system. In bacteria they may be used for digestion of milk.


Pssm-ID: 461703  Cd Length: 382  Bit Score: 392.05  E-value: 2.36e-130
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050     76 PCENFFRFACDGWISNNPIPEDMPSYGVYPWLRHNVDLKLKALLEKSVSRRRDTEAVQKAKILYSSCMNEKAIEKADAKP 155
Cdd:pfam05649   1 PCDDFYQYACGGWLKNHPIPADKSSWGTFDELRERNEKQLREILEEAAASESDPGAVEKAKDLYKSCMDTDAIEKLGLKP 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050    156 LLHILrhspfrwpvleANIGpEGVWSERKFSLLQTLATFRgQYSNSVFIRLYVSPDDKASNEHILKLDQATLSLAVREDF 235
Cdd:pfam05649  81 LKPLL-----------DEIG-GPLANKDKFDLLETLAKLR-RYGVDSLFGFGVGPDDKNSSRNILYLDQPGLGLPDRDYY 147
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050    236 LDNTTEA-KSYRDALYKFMVDTAVLLGAnSSRAEHDMKSVLRLEIKIAEIMIPH-ENRTSEAMYNKMNISELSAMIPQFD 313
Cdd:pfam05649 148 LKDRDEKsAEIREAYKAYIAKLLTLLGA-SEEAAALAEEVLAFETKLAKASLSReERRDPEKTYNPMTLAELQKLAPGID 226
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050    314 WLGYIKKVidtrlyphLKDIGPSENVVVRVPQYFKDLFRILGAERKKTIANYLVWRMVYSRIPNLSRRFQYRWLEFSRVI 393
Cdd:pfam05649 227 WKAYLNAA--------GLPDVPSDEVIVSQPEYLKALSKLLAETPLRTLKNYLIWRLVRSLAPYLSDEFRDANFEFYGTL 298
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050    394 QGTTTlLPQWDKCVNFIESALPYVVGKMFVNVHFQEDKKEMMEELIEGVRWAFIDMLEkENEWMDAGTKRKAQEKARAVL 473
Cdd:pfam05649 299 SGTKQ-RPRWKRCVSLVNGLLGEALGRLYVKKYFPEEAKARVEELVENIKEAFRERLD-ELDWMDEETKKKALEKLDAMT 376

                  ....*.
gi 6755050    474 AKVGYP 479
Cdd:pfam05649 377 VKIGYP 382
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
74-740 0e+00

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 736.48  E-value: 0e+00
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050   74 VDPCENFFRFACDGWISNNPIPEDMPSYGVYPWLRHNVDLKLKALLEKSVSRRRDTEAVQKAKILYSSCMNEKAIEKADA 153
Cdd:cd08662   1 VDPCDDFYQYACGNWLKNHPIPADKSSWGSFSELQDRNEEQLREILEEAASSAADSSAEQKAKDFYKSCMDEEAIEKLGL 80
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050  154 KPLLHILRHspfrwpvleanIGPegvWSERKFSLLQTLATFRGQYSNSVFIRLYVSPDDKASNEHILKLDQATLSLAVRE 233
Cdd:cd08662  81 KPLKPLLDK-----------IGG---LPSLDDLAAELLLALLRRLGVSLLFGLGVSPDPKNSSRNILYLGQPGLGLPDRD 146
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050  234 DFLDntTEAKSYRDALYKFMVDTAVLLGANSSRAEHDMKSVLRLEIKIAEIMIP-HENRTSEAMYNKMNISELSAMIPQF 312
Cdd:cd08662 147 YYLD--EENAEIREAYKKYIAKLLELLGADEEEAEKLAEDVLAFETELAKISLSsEELRDPEKTYNPLTLAELQKLAPSI 224
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050  313 DWLGYIKKVIDtrlyphlkDIGPSENVVVRVPQYFKDLFRILGAERKKTIANYLVWRMVYSRIPNLSRRFQYRWLEFSRV 392
Cdd:cd08662 225 DWKAYLKALGP--------PADDPDKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLDSLAPYLSKEFRDARFFYGKA 296
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050  393 IQGTTTLLPQWDKCVNFIESALPYVVGKMFVNVHFQEDKKEMMEELIEGVRWAFIDMLEkENEWMDAGTKRKAQEKARAV 472
Cdd:cd08662 297 LSGQKEPEPRWKRCVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLE-NLDWMDEETKKKALEKLDAM 375
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050  473 LAKVGYPEFIMNDTYVNEDLKAIKFSeSDYFGNVLQTRKYLAQSDFFWLRKAVPKTEWFTNPTTVNAFYSASTNQIRFPA 552
Cdd:cd08662 376 KVKIGYPDKWRDYSALDIYYDDLNVS-DSYFENVLRLLRFETKRQLAKLGKPVDRTEWSMSPQTVNAYYNPSLNEIVFPA 454
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050  553 GELQKPFFwGTEYPRSLSYGAIGVIVGHEFTHGFDNNGRKYDKNGNLDPWWSVESEEKFKEKTKCMINQYSNYYWKKaGL 632
Cdd:cd08662 455 GILQPPFF-DPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQYSNYEVPP-GL 532
                       570       580       590       600       610       620       630       640
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050  633 NVKGKRTLGENIADNGGLREAFRAYRKWINDRrqgvEEPLLPGITFTNNQLFFLSYAHVRCNSYRPEAAREQVQIGAHSP 712
Cdd:cd08662 533 HVNGKLTLGENIADNGGLRLAYRAYKKWLKEN----GPELPGLEGFTPEQLFFLSFAQVWCSKYRPEALRQLLLTDPHSP 608
                       650       660
                ....*....|....*....|....*...
gi 6755050  713 PQFRVNGAISNFEEFQKAFNCPRNSTMN 740
Cdd:cd08662 609 GKFRVNGPLSNSPEFAEAFNCPPGSPMN 636
PepO COG3590
Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];
68-749 0e+00

Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];


Pssm-ID: 442809 [Multi-domain]  Cd Length: 674  Bit Score: 556.69  E-value: 0e+00
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050   68 SKVNLSVDPCENFFRFACDGWISNNPIPEDMPSYGVYPWLRHNVDLKLKALLEKSVSRRRDTEAVQKaKI--LYSSCMNE 145
Cdd:COG3590  31 ANMDTSVRPGDDFYRYVNGGWLKTTPIPADRSRWGSFNELRERNEARLRAILEEAAAAPAAAGSDEQ-KIgdLYASFMDE 109
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050  146 KAIEKADAKPLLhilrhspfrwPVLE--ANIgpegvwsERKFSLLQTLATFRGQYSNSVFiRLYVSPDDKASNEHILKLD 223
Cdd:COG3590 110 AAIEALGLAPLK----------PDLAriDAI-------KDKADLAALLAALHRAGVGGLF-GFGVDADLKNSTRYIAYLG 171
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050  224 QATLSLAVREDFLDNTTEAKSYRDALYKFMVDTAVLLGANSSRAEHDMKSVLRLEIKIAEIMIPH-ENRTSEAMYNKMNI 302
Cdd:COG3590 172 QGGLGLPDRDYYLKDDEKSAEIRAAYVAHVAKMLELAGYDEADAAAAAEAVLALETALAKAHWSRvELRDPEKTYNPMTV 251
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050  303 SELSAMIPQFDWLGYIKKVidtrlyphlkDIGPSENVVVRVPQYFKDLFRILGAERKKTIANYLVWRMVYSRIPNLSRRF 382
Cdd:COG3590 252 AELAKLAPGFDWDAYLKAL----------GLPAVDEVIVGQPSFFKALDKLLASTPLEDWKAYLRWHLLDSAAPYLSKAF 321
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050  383 QYRWLEF-SRVIQGTTTLLPQWDKCVNFIESALPYVVGKMFVNVHFQEDKKEMMEELIEGVRWAFIDMLEKeNEWMDAGT 461
Cdd:COG3590 322 VDANFDFyGKTLSGQKEQRPRWKRAVALVNGALGEALGQLYVERYFPPEAKARMEELVANLRAAYRERIEN-LDWMSPET 400
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050  462 KRKAQEKARAVLAKVGYPefimnDTYvnEDLKAIKFSESDYFGNVLQTRKylaqsdFFWLR------KAVPKTEWFTNPT 535
Cdd:COG3590 401 KAKALEKLAAFTPKIGYP-----DKW--RDYSGLEIKRDDLVGNVLRASA------FEYQRelaklgKPVDRTEWGMTPQ 467
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050  536 TVNAFYSASTNQIRFPAGELQKPFFwGTEYPRSLSYGAIGVIVGHEFTHGFDNNGRKYDKNGNLDPWWSVESEEKFKEKT 615
Cdd:COG3590 468 TVNAYYNPTMNEIVFPAAILQPPFF-DPKADDAVNYGGIGAVIGHEITHGFDDQGSQFDGDGNLRNWWTPEDRAAFEART 546
                       570       580       590       600       610       620       630       640
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050  616 KCMINQYSNYYWKKaGLNVKGKRTLGENIADNGGLREAFRAYRKwindRRQGVEEPLLPGitFTNNQLFFLSYAHVRCNS 695
Cdd:COG3590 547 KKLVAQYDAYEPLP-GLHVNGKLTLGENIADLGGLSIAYDAYKL----SLKGKEAPVIDG--FTGDQRFFLGWAQVWRSK 619
                       650       660       670       680       690
                ....*....|....*....|....*....|....*....|....*....|....*
gi 6755050  696 YRPEAAREQVQIGAHSPPQFRVNGAISNFEEFQKAFNCPRNSTMNR-GADSCRLW 749
Cdd:COG3590 620 ARDEALRQRLATDPHSPGEFRVNGPVRNLDAFYEAFDVKPGDKMYLaPEDRVRIW 674
Peptidase_M13_N pfam05649
Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of ...
76-479 2.36e-130

Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of organizms including mammals and bacteria. In mammals they participate in processes such as cardiovascular development, blood-pressure regulation, nervous control of respiration, and regulation of the function of neuropeptides in the central nervous system. In bacteria they may be used for digestion of milk.


Pssm-ID: 461703  Cd Length: 382  Bit Score: 392.05  E-value: 2.36e-130
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050     76 PCENFFRFACDGWISNNPIPEDMPSYGVYPWLRHNVDLKLKALLEKSVSRRRDTEAVQKAKILYSSCMNEKAIEKADAKP 155
Cdd:pfam05649   1 PCDDFYQYACGGWLKNHPIPADKSSWGTFDELRERNEKQLREILEEAAASESDPGAVEKAKDLYKSCMDTDAIEKLGLKP 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050    156 LLHILrhspfrwpvleANIGpEGVWSERKFSLLQTLATFRgQYSNSVFIRLYVSPDDKASNEHILKLDQATLSLAVREDF 235
Cdd:pfam05649  81 LKPLL-----------DEIG-GPLANKDKFDLLETLAKLR-RYGVDSLFGFGVGPDDKNSSRNILYLDQPGLGLPDRDYY 147
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050    236 LDNTTEA-KSYRDALYKFMVDTAVLLGAnSSRAEHDMKSVLRLEIKIAEIMIPH-ENRTSEAMYNKMNISELSAMIPQFD 313
Cdd:pfam05649 148 LKDRDEKsAEIREAYKAYIAKLLTLLGA-SEEAAALAEEVLAFETKLAKASLSReERRDPEKTYNPMTLAELQKLAPGID 226
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050    314 WLGYIKKVidtrlyphLKDIGPSENVVVRVPQYFKDLFRILGAERKKTIANYLVWRMVYSRIPNLSRRFQYRWLEFSRVI 393
Cdd:pfam05649 227 WKAYLNAA--------GLPDVPSDEVIVSQPEYLKALSKLLAETPLRTLKNYLIWRLVRSLAPYLSDEFRDANFEFYGTL 298
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050    394 QGTTTlLPQWDKCVNFIESALPYVVGKMFVNVHFQEDKKEMMEELIEGVRWAFIDMLEkENEWMDAGTKRKAQEKARAVL 473
Cdd:pfam05649 299 SGTKQ-RPRWKRCVSLVNGLLGEALGRLYVKKYFPEEAKARVEELVENIKEAFRERLD-ELDWMDEETKKKALEKLDAMT 376

                  ....*.
gi 6755050    474 AKVGYP 479
Cdd:pfam05649 377 VKIGYP 382
Peptidase_M13 pfam01431
Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which ...
538-748 2.23e-77

Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which are known, or believed to activate or inactivate oligopeptide (pro)-hormones such as opioid peptides. The family also contains a bacterial member believed to be involved with milk protein cleavage.


Pssm-ID: 279739 [Multi-domain]  Cd Length: 205  Bit Score: 247.71  E-value: 2.23e-77
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050    538 NAFYSASTNQIRFPAGELQKPFFwGTEYPRSLSYGAIGVIVGHEFTHGFDNNGRKYDKNGNLDPWWSVESEEKFKEKTKC 617
Cdd:pfam01431   1 NAYYQPNRNEIVFPAAILQPPFF-DPNYPRAVNYGGIGNVIAHEITHGFDDQGAQFDKDGNLRSWWTDEDAEEFKDRAQC 79
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6755050    618 MINQYSNYYWKKAGLNVKGKRTLGENIADNGGLREAFRAYRKwindrRQGVEEPLLPGI-TFTNNQLFFLSYAHVRCNSY 696
Cdd:pfam01431  80 LIEQYSEYTPPDGTKCANGTLTLGENIADLGGLTIALRAYKK-----LLSANETVLPGFeNLTPDQLFFRGAAQIWCMKQ 154
                         170       180       190       200       210
                  ....*....|....*....|....*....|....*....|....*....|..
gi 6755050    697 RPEAAREQVQIGAHSPPQFRVNGAISNFEEFQKAFNCPRNSTMNRgADSCRL 748
Cdd:pfam01431 155 SPAEVLRQLLVDPHSPPEFRVNGVMSNMPAFYEAFNCPEGDKMNP-EPRCRL 205
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH